Relistor is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Salix Pharmaceuticals, Inc.. The primary component is Methylnaltrexone Bromide.
| Product ID | 65649-150_1357dc78-e4c6-4f46-818b-b3bf1f02ef97 |
| NDC | 65649-150 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Relistor |
| Generic Name | Methylnaltrexone Bromide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-08-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208271 |
| Labeler Name | Salix Pharmaceuticals, Inc. |
| Substance Name | METHYLNALTREXONE BROMIDE |
| Active Ingredient Strength | 150 mg/1 |
| Pharm Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA],Quaternary Ammonium Compounds [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2016-07-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208271 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-07-19 |
| Marketing End Date | 2017-06-30 |
| Marketing Category | NDA |
| Application Number | NDA208271 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-07-19 |
| Marketing Category | NDA |
| Application Number | NDA208271 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-07-19 |
| Ingredient | Strength |
|---|---|
| METHYLNALTREXONE BROMIDE | 150 mg/1 |
| SPL SET ID: | c488fb7c-0a5b-487c-b452-996809d1cb99 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 65649-150 | Relistor | Methylnaltrexone bromide |
| 65649-551 | Relistor | Methylnaltrexone bromide |
| 65649-552 | Relistor | Methylnaltrexone bromide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RELISTOR 78939607 3535582 Live/Registered |
SALIX PHARMACEUTICALS, INC. 2006-07-28 |
![]() RELISTOR 77324836 3592407 Dead/Cancelled |
SALIX PHARMACEUTICALS, INC. 2007-11-08 |